Research ExplorerPublicationsCombination of osteopontin and activated leukocyte cell adhe...

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer.

Links

  • Maike Henningsen
  • R M Wirtz
  • K T Kalogeras
  • Karin Milde-Langosch
  • M Schmidt
  • Isabell Witzel
  • A G Eleftheraki
  • C Papadimitriou
  • Fritz Jänicke
  • E Briassoulis
  • D Pectasides
  • A Rody
  • G Fountzilas
  • Volkmar Müller

Related Research units

Abstract

To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer.

Bibliographical data

Original languageGerman
Article number7
ISSN0007-0920
Publication statusPublished - 2010
pubmed 20736952